← All trials
NCT05536596
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2022
- Primary completion
- Jun 30, 2024
- Completion date
- Dec 31, 2024
- First posted
- Sep 13, 2022
- Last posted
- Sep 13, 2022
- Enrollment
- 220
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universitat Internacional de CatalunyaLead sponsor
- Universitat Internacional de CatalunyaReponsible party - principal investigator
- Universidad de los AndesCollaborator
- Universidad de los AndesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.